Molecular and functional diversity of ATP-sensitive K+ channels: The pathophysiological roles and potential drug targets

Folia Pharmacologica Japonica

Volumn 122, Issue 3, 2003, Pages 243-250

  Nakaya, Haruaki ^a   Miki, Takashi ^a   Seino, Susumu ^a   Yamada, Katsuya ^b   Inagaki, Nobuya ^b   Suzuki, Masashi ^a   Sato, Toshiaki ^a   Yamada, Mitsuhiko ^c   Matsushita, Kenji ^c   Kurachi, Yoshihisa ^c   Arita, Makoto ^d  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d Yufuin Kosei nenkin Hospital   (Japan)

Author keywords

ATP sensitive K+ channel; Cardiovascular system; Central nervous system; K+ channel opener; Mitochondria

Indexed keywords

ADENOSINE TRIPHOSPHATE; MINOXIDIL; NICORANDIL; NUCLEOTIDE; POTASSIUM CHANNEL; PROTEIN KIR6.2; PROTEIN SUBUNIT; PROTEIN SUR2; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 1; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

CHANNEL GATING; DRUG TARGETING; ELECTROCARDIOGRAM; GENE DELETION; GENETIC CODE; GUINEA PIG; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; HYPOXIA; KNOCKOUT MOUSE; METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRINZMETAL ANGINA PECTORIS; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; SARCOLEMMA; SEIZURE SUSCEPTIBILITY; SUDDEN DEATH; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG DESIGN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MITOCHONDRIA, HEART; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; QUALITY OF LIFE; RECEPTORS, DRUG;

EID: 0141591553     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.122.243     Document Type: Review

References (33)

1. + channels in cardiac muscle. Nature. 1983;305:147-148.
2. + currents in pancreatic β cells. Naunyn-Scmiedbergs Arch Pharmacol. 1988;337:225-230.
3. + current by nicorandil (2-nicontinamidoethyl nitrate) in isolated ventricular myocytes. J Pharmacol Exp Ther. 1989;250:278-285.
4. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270:1166-1170.
5. + channels. Neuron. 1996;16:1011-1017.
6. + channel. J Biol Chem. 1996;271:24321-24324.
7. Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol. 1999;61:337-362.
8. O'Rouke B. Pathophysiological and protective roles of mitochondrial ion channels. J Physiol (Lond). 2000;529:23-36.
9. + channel. J Physiol (Lond). 1997;499:715-720.
10. Miki T, Suzuki M, Shibasaki T, et al. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 2002;8:466-472.
11. Yamada K, Ji J-J, Yuan H, et al. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science. 2001;292:1543-1546.
12. Mourre C, Ben Ari Y, Bernardi H, Fosset M, Lazdunski M. Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices. Brain Res. 1989;486:159-164.
13. ATP channel-deficient mice. Proc Natl Acad Sci USA. 1998;95:10402-10406.
14. Depaulis A, Vergnes M, Marescaux C. Endogenous control of epilepsy: the nigral inhibitory system. Prog Neurobiol. 1994;42:33-52.
15. Auer RN, Siesjö BK. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol. 1988;24:699-707.
16. + channels in the brain: sensors of hypoxic conditions. News Physiol Sci. 2002;17:127-130.
17. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223-233.
18. + channels in the mitochondrial inner membrane. Nature. 1991;352:244-247.
19. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81:1072-1082.
20. Suzuki M, Li RA, Miki T, et al. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res. 2001;88:570-577.
21. ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest. 2002;109:509-516.
22. Suzuki M, Saito T, Sato T, et al. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation. 2003;107: 682-685.
23. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97: 2463-2469.
24. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res. 2001;89:1177-1183.
25. ATP channels in cardioprotection. Basic Res Cardiol. 2000;95:285-289.
26. ATP channels attenuates the ouabain-induced calcium overload in mitochondria. Circ Res. 2001;89:856-858.
27. Sato T, Sasaki N, O'Rourke B, Marbán E. Nicorandil, a potent cardioprotective agent, acts by pening of mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514-518.
28. ATP channels in preconditioning. Circ Res. 2000;87:845-855.
29. The IONA study group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;35:1269-1275.
30. + channels in the absence of the sulphonylurea receptor. Nature. 1997;387:179-183.
31. Nichols CG, Shyng S-L, Nestorowicz A, et al. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science. 1996;272:1785-1787.
32. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the β cell high-affinity sulfonylurea receptor: a regulation of insulin secretion. Science. 1995;268:423-426.
33. ATP channel openers. EMBO J. 2000; 19:6644-6651.